Danvers, MA, United States of America

Michael D Nieskoski

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dartmouth College. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Michael D Nieskoski in Therapeutic Agent Uptake

Introduction

Michael D Nieskoski is an accomplished inventor based in Danvers, MA (US). He has made significant contributions to the field of medical technology, particularly in enhancing the delivery of therapeutic agents to disease sites within the human body. His innovative approach has the potential to improve treatment outcomes for patients.

Latest Patents

Nieskoski holds a patent for "Systems and methods for enhancing uptake of therapeutic agent from bloodstream into disease site." This patent describes a method that involves applying negative pressure to a disease site, creating a pressure differential that facilitates the transport of therapeutic agents from the bloodstream into the affected area. The system includes a partial enclosure that interfaces with the patient's exposed surface and a pump that evacuates air to produce a partial vacuum, thereby enhancing the uptake of the therapeutic agent.

Career Highlights

Nieskoski is affiliated with Dartmouth College, where he continues to work on innovative solutions in the medical field. His research focuses on improving therapeutic delivery systems, which can significantly impact patient care and treatment efficacy.

Collaborations

One of his notable collaborators is Stuart B Trembly, with whom he has worked on various projects aimed at advancing medical technologies.

Conclusion

Michael D Nieskoski's work exemplifies the intersection of innovation and healthcare, showcasing how inventive solutions can lead to improved therapeutic outcomes for patients. His contributions are paving the way for future advancements in medical treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…